Parameter | Frequency (%) in age categories (n = 220) | p value | ||
---|---|---|---|---|
1–≤ 12 months n = 110 (%) | ≥ 12–60 months n = 57 (%) | ≥ 60 months–12 years n = 53 (%) | ||
Past clinical history (6Â months)-conditions to seek antimicrobial medications | ||||
 UTI | 56 (50.1) | 34 (59.6) | 24 (45.1) | p = 0.03 |
 ARTI | 66 (0.6) | 45 (78.9) | 30 (56.6) | p = 0.03 |
 AGE | 32 (29.1) | 14 (24.6) | 14 (26.4) | – |
 Infection in CNS | 4 (3.6) | 6 (10.5) | 12 (22.6) | – |
 IE | – | 1 (1.7) | 2 (3.7) | – |
 Abscess | 12 (10.9) | 10 (17.5) | 12 (22.6) | – |
 Accidental wounds | 3 (2.7) | 12 (21) | 23 (43.3) | p = 0.02 |
 Use of antimicrobials | 100% | 100% | 100% | – |
 ICU admissions | 3 (2.7) | 3 (5.2) | 4 (7.5) | – |
Commonly used antimicrobials in last 6Â months | ||||
 Beta-lactams | ||||
  Penicillin | 4 (7.2) | 8 (21) | 3 | – |
  Cephalosporin | 43 | 31 | 30 | p = 0.02 |
  Cefuroxime | 4 | 5 | 3 | – |
  Ceftriaxone | 9 | 4 | 4 | – |
  Cefotaxime | 7 | 2 | 5 | – |
  Cefixime | 23 | 20 | 18 | p = 0.02 |
  Meropenem | 8 | 2 | 4 | – |
 Beta lactam/inhibitor | 22 | 9 | 4 | – |
Quinolones | 12 | 5 | 3 | – |
Macrolides | 15 | 2 | 5 | – |
Urinary anti-septic | 4 | – | – | – |
Glycopeptides | 2 | – | 4 | – |
Current episode | ||||
Duration of illness prior to seek care (hours ± SD) | 8 ± 4 | 12 ± 3 | 22 ± 6 | p < 0.05 |
Mode of initial treatment consultation of | ||||
 GP—local medical practitioner | 23 | 24 | 24 |  |
 Consultant pediatrician | 45 | 11 | 21 | p < 0.05 |
Empirical antimicrobial prescription rate (%) | 100% | 100% | 100% | – |
 UFR done (n) | 34 | 24 | 26 | – |
 Urine culture done (n) | 22 | 12 | 12 | – |
 Culture positive (n) | 16 | 9 | 8 | – |
 Duration of treatment (hours ± SD) | 18 ± 4 h | 20 ± 3 h | 25 ± 8 h | – |
Inward care | ||||
 Period taken to inward care following GP care | 20 ± 4.4 h | 22 ± 4.6 h | 28 ± 4 h | – |
 Inward Urine culture done | 100% | 100% | 100% | – |
 Inward Urine culture positivity (%) | 31.4% | 36.8% | 32.2% | – |
Change of prescribed antimicrobials | ||||
 Escalation | 80% | 88% | 92% | p = 0.02 |
 De-escalation | 16% | 6% | 4% | – |
 Not changed | 4% | 6% | 4% | – |
Out come | ||||
 Hospital stay (mean days ± SD) | 3 ± 1 | 3.5 ± 0.5 | 4 ± 0.8 | – |
 Complications | ||||
  Septicemia | 5 | 3 | 5 | – |
  Renal abscess | 4 | 4 | 4 | – |
  Infective endocarditis | 2 | 4 | 4 | – |
USS-abdomen | ||||
 Normal | 90 | 50 | 44 | p = 0.02 |
 Pyelonephritis | 16 | 5 | 6 |  |
 Structural anomalies | ||||
  Scaring | 2 | 2 | 3 | – |
Follow up detail in next 18-month period | ||||
 Frequency of UTI per year | 1.5 ± 1 | 1 ± 1 | 2 ± 1 | – |
Compliance rate of antimicrobial use | ||||
 First day | 100% | 100% | 100% | – |
 Completion of dosage | 60 ± 10% | 50 ± 10% | 52 ± 10% | – |
Average cost for antimicrobials (LKR) | ||||
 1st episode | 88 ± 12 | 112 ± 20 | 132 ± 54 | – |
 Total in last 24 months | 1200 ± 300 | 1300 ± 280 | 1660 ± 290 | – |